Companies: 10,795·Total market cap: $144.5T
AxoGen, Inc.

AxoGen, Inc.

AXGNNASDAQHealthcare● Active
$41.46
$-1.34(-3.13%)
Market Cap$2.2B
P/E Ratio
52W High$45.83
52W Low$9.22

AxoGen, Inc. (AXGN) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · AXGN · as of Jun 8, 2026

Activity summary

Buy transactions

0

P-Purchase only

Sell transactions

43

12 Months

Buy/Sell ratio

0.00

Buy/Sell (by trades)

Overall sentiment

BEARISH
↑ Buy 0%Active transactions only · RSU vesting excluded100% Sell ↓

AxoGen, Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 8, 2026

AXGN insider buying and selling by quarter

AXGN insider selling · AXGN insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling
748K374K0
2025 Q3
2025 Q4
2026 Q1
2026 Q2

Mobile shows last 4Q · Desktop shows full 8Q

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 8, 2026

Active insiders

Most active in past 12 months · AXGN ceo insider trading

Showing all insiders · Click a card to filter the transactions table below

Aggregated from reportingName · top 5 by trade count (12M) · no extra API

Recent insider transactions

AXGN executive sell shares · AXGN board member insider trading · AXGN insider trading SEC filing

Showing 68 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

Wendell Amy McBride

Director

Option

Date

May 8

Shares

1,647

Price

$14.85

Value

$24K

View Form 4 on SEC.gov

Wendell Amy McBride

Director

Sale

Date

May 8

Shares

1,647

Price

$42.60

Value

$70K

View Form 4 on SEC.gov

JOHNSON JOHN

Director

Option

Date

May 7

Shares

11,050

Price

$7.04

Value

$78K

View Form 4 on SEC.gov

JOHNSON JOHN

Director

Sale

Date

May 7

Shares

11,050

Price

$43.26

Value

$478K

View Form 4 on SEC.gov

Weiler Kathy Johnson

Director

Option

Date

May 7

Shares

16,344

Price

$6.95

Value

$114K

View Form 4 on SEC.gov

Weiler Kathy Johnson

Director

Sale

Date

May 7

Shares

16,344

Price

$44.09

Value

$721K

View Form 4 on SEC.gov

Kemp Jens

Chief Marketing Officer

Sale

Date

May 7

Shares

4,000

Price

$43.44

Value

$174K

View Form 4 on SEC.gov

Hartley Lindsey Marie

CFO

Option

Date

May 7

Shares

2,963

Price

$8.27

Value

$25K

View Form 4 on SEC.gov

Hartley Lindsey Marie

CFO

Sale

Date

May 7

Shares

573

Price

$43.67

Value

$25K

View Form 4 on SEC.gov

Hartley Lindsey Marie

CFO

Option

Date

May 7

Shares

2,500

Price

$8.20

Value

$21K

View Form 4 on SEC.gov

Hartley Lindsey Marie

CFO

Sale

Date

May 7

Shares

478

Price

$43.67

Value

$21K

View Form 4 on SEC.gov

Quackenbush Doris

Sales VP

Sale

Date

May 7

Shares

3,878

Price

$43.51

Value

$169K

View Form 4 on SEC.gov

DeVinney Erick Wayne

Chief Innovation Officer

Option

Date

Mar 16

Shares

11,575

Price

Value

View Form 4 on SEC.gov

DeVinney Erick Wayne

Chief Innovation Officer

Sale

Date

Mar 16

Shares

5,221

Price

$32.84

Value

$171K

View Form 4 on SEC.gov

DeVinney Erick Wayne

Chief Innovation Officer

Option

Date

Mar 16

Shares

6,363

Price

Value

View Form 4 on SEC.gov

DeVinney Erick Wayne

Chief Innovation Officer

Other

Date

Mar 16

Shares

2,870

Price

$32.84

Value

$94K

View Form 4 on SEC.gov

Hartley Lindsey Marie

CFO

Option

Date

Mar 16

Shares

5,000

Price

Value

View Form 4 on SEC.gov

Hartley Lindsey Marie

CFO

Other

Date

Mar 16

Shares

1,968

Price

$32.84

Value

$65K

View Form 4 on SEC.gov

Hartley Lindsey Marie

CFO

Option

Date

Mar 16

Shares

4,000

Price

Value

View Form 4 on SEC.gov

Hartley Lindsey Marie

CFO

Other

Date

Mar 16

Shares

1,574

Price

$32.84

Value

$52K

View Form 4 on SEC.gov

Kemp Jens

Chief Marketing Officer

Award

Date

Feb 26

Shares

50,670

Price

Value

View Form 4 on SEC.gov

Kemp Jens

Chief Marketing Officer

Other

Date

Feb 26

Shares

15,414

Price

$31.90

Value

$492K

View Form 4 on SEC.gov

Kemp Jens

Chief Marketing Officer

Other

Date

Mar 1

Shares

2,952

Price

$30.65

Value

$90K

View Form 4 on SEC.gov

DeVinney Erick Wayne

Chief Innovation Officer

Award

Date

Feb 26

Shares

33,780

Price

Value

View Form 4 on SEC.gov

DeVinney Erick Wayne

Chief Innovation Officer

Other

Date

Feb 26

Shares

10,702

Price

$31.90

Value

$341K

View Form 4 on SEC.gov

⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar

1 / 3

Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About AXGN insider trading

AXGN insider trades

AxoGen, Inc. (AXGN) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Hartley Lindsey Marie (CFO), Wendell Amy McBride (Director), JOHNSON JOHN (Director). Over the past 12 months, 5 insiders have filed transactions with the SEC. AXGN insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For AxoGen, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic
acquisitionOrDisposition field:
A = Acquisition (buy) · D = Disposition (sell)
RSU vesting (M-Exempt) excluded from sentiment
Form 4SEC filing required within 2 business days of any insider transaction
10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot
Open MktDirect purchase or sale on the open market (excludes awards, options)

Frequently asked questions

AXGN insider trading · 5 questions

The insiders of AxoGen, Inc. (AXGN) include executives and directors such as Hartley Lindsey Marie (CFO), Wendell Amy McBride (Director), JOHNSON JOHN (Director), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

AXGN board member insider tradingwho are AXGN insidersAXGN insider rosterAxoGen, Inc. executives insider activity

Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026